Ly6/neurotoxin 1 (LYNX1) has been suggested as a prognostic factor in ovarian serous cystadenocarcinoma (Liu et al., 2020) and glioblastoma (Ren et al., 2022). This evidence concerns the gene LYNX1 and ovarian serous cystadenocarcinoma.